Corneal Uptake of Riboflavin Eye Drops

• Status: Completed
• Trial end date: 2020-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The overall objective of this study is to optimise the corneal cross-linking standard protocol in terms of a more economical use of the resource "medical personnel" and in terms of increased patient participation. If it can be shown that the riboflavin necessary for corneal cross-linking does not necessarily have to be applied directly on the cornea (as currently performed by the nurses), but can also be applied in the inferior fornix (as it would be performed by patients in the context of self-application), then it would be conceivable to transfer this task from medical staff to the patients.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Luzerner Kantonsspital
• Treatments: Ophthalmic Solutions; Riboflavin

Criteria

Inclusion Criteria:

• Healthy clinical staff members of the Dept. of Ophthalmology at the Lucerne Cantonal Hospital will be evaluated for study inclusion.

• Signed written informed consent form

Exclusion Criteria:

• Aged < 18 years

• Any ocular or systemic diseases with ocular side effects

• Medication with potential ocular side effects

• Epilepsia, due to the flickering light of the fluorophotometer used to measure anterior chamber riboflavin concentration